Abstract:BACKGROUND Ubiquitin-specific protease 15 (USP15) is an important member of the ubiquitin-specific protease family, the largest deubiquitinase subfamily, whose expression is dysregulated in many types of cancer. However, the biological function and the underlying mechanisms of USP15 in gastric cancer (GC) progression have not been elucidated. AIM To explore the biological role and underlying mechanisms of USP15 in GC progression. METHODS Bioinformatics databases and western blot analysis were utilized to determine the expression of USP15 in GC. Immunohistochemistry was performed to evaluate the correlation between USP15 expression and clinicopathological characteristics of patients with GC. A loss- and gain-of-function experiment was used to investigate the biological effects of USP15 on GC carcinogenesis. RNA sequencing, immunofluorescence, and western blotting were performed to explore the potential mechanism by which USP15 exerts its oncogenic functions. RESULTS USP15 was up-regulated in GC tissue and cell lines. The expression level of USP15 was positively correlated with clinical characteristics (tumor size, depth of invasion, lymph node involvement, tumor-node-metastasis stage, perineural invasion, and vascular invasion), and was related to poor prognosis. USP15 knockdown significantly inhibited cell proliferation, invasion and epithelial-mesenchymal transition (EMT) of GC in vitro, while overexpression of USP15 promoted these processes. Knockdown of USP15 inhibited tumor growth in vivo. Mechanistically, RNA sequencing analysis showed that USP15 regulated the Wnt signaling pathway in GC. Western blotting confirmed that USP15 silencing led to significant down-regulation of beta-catenin and Wnt/beta-catenin downstream genes (c-myc and cyclin D1), while overexpression of USP15 yielded an opposite result and USP15 mutation had no change. Immunofluorescence indicated that USP15 promoted nuclear translocation of beta-catenin, suggesting activation of the Wnt/beta-catenin signaling pathway, which may be the critical mechanism promoting GC progression. Finally, rescue experiments showed that the effect of USP15 on gastric cancer progression was dependent on Wnt/beta-catenin pathway. CONCLUSION USP15 promotes cell proliferation, invasion and EMT progression of GC via regulating the Wnt/beta-catenin pathway, which suggests that USP15 is a novel potential therapeutic target for GC.

112 USP18 Promotes Cell Proliferation and Suppressed Apoptosis in Cervical Cancer Cells Via Akt Signaling Pathway

USP18 Promotes Breast Cancer Growth by Upregulating EGFR and Activating the AKT/Skp2 Pathway

USP14 Promotes the Proliferation of Cervical Cancer Via Upregulating Β-Catenin

USP18 promotes colon adenocarcinoma progression via targeting the ERK-MNK signaling pathway

A Regulatory Network Analysis of the Importance of USP15 in Breast Cancer Metastasis and Prognosis

Ubiquitin-specific protease 22: a novel molecular biomarker in cervical cancer prognosis and therapeutics

Comprehensive Analysis of Ubiquitin‐specific Protease 1 Reveals Its Importance in Hepatocellular Carcinoma

Effects of ubiquitin-specific proteases 2-69 on proliferation of breast cancer cells

USPs in Pancreatic Ductal Adenocarcinoma: A Comprehensive Bioinformatic Analysis of Expression, Prognostic Significance, and Immune Infiltration.

USP18 Is Associated with PD-L1 Antitumor Immunity and Improved Prognosis in Colorectal Cancer

Downregulation of Ubiquitin-Specific Protease 14 (USP14) Inhibits Breast Cancer Cell Proliferation and Metastasis, but Promotes Apoptosis

Ubiquitin specific protease 21 upregulation in breast cancer promotes cell tumorigenic capability and is associated with the NOD-like receptor signaling pathway

Bulk and Single Cells Transcriptomes with Experimental Validation Identify USP18 As a Novel Glioma Prognosis and Proliferation Indicator

The USP18-FBXO6 axis maintains the malignancy of ovarian cancer

Ubiquitin-specific Protease 15 Contributes to Gastric Cancer Progression by Regulating the Wnt/β-catenin Signaling Pathway.

Downregulation of USP18 Inhibits Growth and Induces Apoptosis in Hepatitis B Virus-Related Hepatocellular Carcinoma Cells by Suppressing BCL2L1

Deubiquitinating enzyme USP42 promotes breast cancer progression by inhibiting JNK/p38-mediated apoptosis

USP53 Affects the Proliferation and Apoptosis of Breast Cancer Cells by Regulating the Ubiquitination Level of ZMYND11

Expression of ubiquitin specific peptidose 53 in colorectal cancer tissues and its inhibitory effect on HCT116 cells

Ubiquitin-specific Peptidase 39 Regulates the Process of Proliferation and Migration of Human Ovarian Cancer Via P53/p21 Pathway and EMT

USP7 inhibits TIMP2 by up-regulating the expression of EZH2 to activate the NF-κB/PD-L1 axis to promote the development of cervical cancer